美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
CANAGLIFLOZIN	210297	001	ANDA	CANAGLIFLOZIN	TABLET; ORAL	100MG	No	No	2020/11/20 (TA)	--	SANDOZ INC	None (Tentative Approval)
CANAGLIFLOZIN	210503	002	ANDA	CANAGLIFLOZIN	TABLET;ORAL	300MG	No	No	2022/01/28 (TA)	--	LAURUS LABS LTD	None (Tentative Approval)
CANAGLIFLOZIN	210451	002	ANDA	CANAGLIFLOZIN	TABLET; ORAL	300mg	No	No	2022/06/14 (TA)	--	TEVA PHARMS USA	None (Tentative Approval)
CANAGLIFLOZIN	210541	001	ANDA	CANAGLIFLOZIN	TABLET;ORAL	100MG	No	No	2023/02/13 (TA)	--	ZYDUS PHARMS USA INC	None (Tentative Approval)
CANAGLIFLOZIN	210541	002	ANDA	CANAGLIFLOZIN	TABLET;ORAL	300MG	No	No	2023/02/13 (TA)	--	ZYDUS PHARMS USA INC	None (Tentative Approval)
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE	210542	001	ANDA	CANAGLIFLOZIN;METFORMIN HYDROCHLORIDE	TABLET;ORAL	50MG;500MG	No	No	2023/02/16 (TA)	--	ZYDUS PHARMS USA INC	None (Tentative Approval)
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE	210542	002	ANDA	CANAGLIFLOZIN;METFORMIN HYDROCHLORIDE	TABLET;ORAL	50MG;1000MG	No	No	2023/02/16 (TA)	--	ZYDUS PHARMS USA INC	None (Tentative Approval)
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE	210542	003	ANDA	CANAGLIFLOZIN;METFORMIN HYDROCHLORIDE	TABLET;ORAL	150MG;500MG	No	No	2023/02/16 (TA)	--	ZYDUS PHARMS USA INC	None (Tentative Approval)
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE	210542	004	ANDA	CANAGLIFLOZIN;METFORMIN HYDROCHLORIDE	TABLET;ORAL	150MG;1000MG	No	No	2023/02/16 (TA)	--	ZYDUS PHARMS USA INC	None (Tentative Approval)